Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …

Background Sarcopenia, defined using abdominal computed tomography (CT), has been
used as a prognostic marker for patients with idiopathic pulmonary fibrosis (IPF). However …

Background & aims Sarcopenia is common in patients with chronic obstructive pulmonary
disease (COPD). Serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a …

Objectives Sarcopenia is a syndrome characterized by reduced muscle mass and function. It
is well-recognized as a complication in chronic diseases such as chronic obstructive …

Background Sarcopenia is a geriatric syndrome with progressive loss of skeletal muscle
mass and function and has a negative impact on clinical outcomes associated with chronic …

Background Sarcopenia can contribute to negative outcomes in patients with various lung
diseases. However, whether sarcopenia affects prognosis in patients with idiopathic …

Background and objective Recent research has highlighted the fundamental role of
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …

Background Sarcopenia is an important prognostic factor of lung cancer. The serum
creatinine/cystatin C ratio (CCR) and the sarcopenia index (SI, serum creatinine× cystatin C …

Objectives The peak expiratory flow rate (PEFR) is known to decrease in patients with
sarcopenia. However, little is known about the clinical impact of the PEFR in idiopathic …

Background Sarcopenia gained importance in the evaluation of patients with chronic
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …